NovaMed Company Profile (NASDAQ:NOVA)

About NovaMed (NASDAQ:NOVA)

NovaMed logoNovaMed, Inc. is a health care services company and an owner and operator of ambulatory surgery centers (ASCs). The Company’s primary focus is to acquire, develop and operate ASCs in joint ownership with physicians throughout the United States. As of March 15, 2010, it owned and operated 37 ASCs located in 19 states. As of March 15, 2010, 13 of its 37 ASCs offer surgical services in specialties other than ophthalmology. As of March 15, 2010, it owned a majority interest in 35 of its ASCs, with the noncontrolling interests generally being held by physicians. It owns 100% of the equity interests in two of its ASCs. It also owns and operates optical laboratories, an optical products purchasing organization, a marketing products and services business, and a call center and marketing solutions business. In addition to its surgical facilities and optical products businesses, NovaMed, Inc. provides management services to two eye care practices pursuant to long-term service agreements.

Industry, Sector and Symbol:
  • Sector: Services
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NOVA
  • CUSIP: N/A
  • Web: N/A
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
  • Dividend Yield: 1.0%
Frequently Asked Questions for NovaMed (NASDAQ:NOVA)

What is NovaMed's stock symbol?

NovaMed trades on the NASDAQ under the ticker symbol "NOVA."

Where is NovaMed's stock going? Where will NovaMed's stock price be in 2017?

1 analysts have issued 12 month price targets for NovaMed's shares. Their forecasts range from $2.00 to $2.00. On average, they expect NovaMed's share price to reach $2.00 in the next twelve months. View Analyst Ratings for NovaMed.

Who are some of NovaMed's key competitors?

How do I buy NovaMed stock?

Shares of NovaMed can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

MarketBeat Community Rating for NovaMed (NASDAQ NOVA)
Community Ranking:  0.3 out of 5 ()
Outperform Votes:  1 (Vote Outperform)
Underperform Votes:  15 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about NovaMed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for NovaMed (NASDAQ:NOVA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00 (Infinity upside)

Analysts' Ratings History for NovaMed (NASDAQ:NOVA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/28/2017Cantor FitzgeraldReiterated RatingNeutral$2.00N/AView Rating Details
(Data available from 7/28/2015 forward)


Earnings History for NovaMed (NASDAQ:NOVA)
Earnings by Quarter for NovaMed (NASDAQ:NOVA)
Earnings History by Quarter for NovaMed (NASDAQ NOVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/17/2011$0.24$0.26ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for NovaMed (NASDAQ:NOVA)

No earnings estimates for this company have been tracked by


Dividend History for NovaMed (NASDAQ:NOVA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for NovaMed (NASDAQ:NOVA)
No insider trades for this company have been tracked by


Headline Trends for NovaMed (NASDAQ:NOVA)
Latest Headlines for NovaMed (NASDAQ:NOVA)



NovaMed (NOVA) Chart for Friday, July, 28, 2017

This page was last updated on 7/28/2017 by Staff